Consequently, MPM-1 holds promise as a potential therapeutic agent for tumors, contributing to the advancement of cancer diagnostics and treatment, and providing valuable insights for the future development of innovative fluorescence probes for clinical imaging. The gene discussed is MTLN; the disease is cancer.